Clinical Trial: Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ Prolapse

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Pelvic Organ Prolapse Correction Plus Preventive Treatment of Urinary Stress Incontinence vs. Correction of Pelvic Organ Prolapse Followed by

Brief Summary:

The incidence of pelvic organ prolapse (POP) in parous women is estimated over 50%. A variety of urinary, bowel and sexual symptoms may be associated with POP. Moreover, a proportion of women who underwent a surgical correction of POP may occur post-surgical urinary incontinence and, thus, if this last presents as genuine stress-type or mixed-type, a second surgical intervention may be required. At this proposal, with the aim to reduce the incidence of postoperative urinary incontinence, the addition of a preventive continence procedure to a POP repair intervention has been widely proposed, but the potential benefits needs to be balanced against potential disadvantages.

Based on these considerations, the aim of this trial will be to compare two different surgical strategies for women with POP without urinary stress incontinence. Specifically, the efficacy to associate and to follow a preventive continence procedure to the correction of POP will be compared.


Detailed Summary:

Women with POP not associated to urinary stress incontinence will be enrolled and randomized in two arms(groups A and B). Patients of group A will be treated with unique surgery (correction of POP plus preventive continence procedure), whereas in patients of group B POP will be surgically corrected and, in case of stress or mixed postoperative incontinence, a further intervention for urinary stress incontinence will be tailored.

All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, ultrasonographic and urodynamic evaluations. During the study, the clinical outcomes, and the adverse experience will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.


Sponsor: University Magna Graecia

Current Primary Outcome: efficacy (cure rate) [ Time Frame: 12 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • intra-operative complication rate [ Time Frame: one day ]
  • postoperative complications rate [ Time Frame: 12 months ]
  • sexual function [ Time Frame: 12 months ]
  • quality of life [ Time Frame: 12 months ]
  • Failure rate [ Time Frame: 12 months ]
  • Recurrence rate [ Time Frame: 12 months ]


Original Secondary Outcome: Same as current

Information By: University Magna Graecia

Dates:
Date Received: June 12, 2008
Date Started: June 2008
Date Completion:
Last Updated: April 5, 2013
Last Verified: April 2013